BR9806318A - Polipeptìdeo pde8, polinucleotìdeo codificando o mesmo, dna, polinucleotìdeo anti-sentido, construção de expressão, célula hospedeira, processo para produzir um polipeptìdeo pde8, anticorpo, hibridoma, anticorpo anti-idiotipo, processo para identificar um composto parceiro de ligação espefcìfico de um polipeptìdeo pde8a, e de polinucleotìdeo pde8a, composto, e, composição. - Google Patents

Polipeptìdeo pde8, polinucleotìdeo codificando o mesmo, dna, polinucleotìdeo anti-sentido, construção de expressão, célula hospedeira, processo para produzir um polipeptìdeo pde8, anticorpo, hibridoma, anticorpo anti-idiotipo, processo para identificar um composto parceiro de ligação espefcìfico de um polipeptìdeo pde8a, e de polinucleotìdeo pde8a, composto, e, composição.

Info

Publication number
BR9806318A
BR9806318A BR9806318-9A BR9806318A BR9806318A BR 9806318 A BR9806318 A BR 9806318A BR 9806318 A BR9806318 A BR 9806318A BR 9806318 A BR9806318 A BR 9806318A
Authority
BR
Brazil
Prior art keywords
antibody
pde8a
pde8
polynucleotide
polypeptide
Prior art date
Application number
BR9806318-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Kate Loughney
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25491965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9806318(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Icos Corp filed Critical Icos Corp
Publication of BR9806318A publication Critical patent/BR9806318A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cereal-Derived Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
BR9806318-9A 1997-10-16 1998-10-16 Polipeptìdeo pde8, polinucleotìdeo codificando o mesmo, dna, polinucleotìdeo anti-sentido, construção de expressão, célula hospedeira, processo para produzir um polipeptìdeo pde8, anticorpo, hibridoma, anticorpo anti-idiotipo, processo para identificar um composto parceiro de ligação espefcìfico de um polipeptìdeo pde8a, e de polinucleotìdeo pde8a, composto, e, composição. BR9806318A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/951,648 US5932465A (en) 1997-10-16 1997-10-16 Phosphodiesterase 8A
PCT/US1998/021956 WO1999019495A1 (en) 1997-10-16 1998-10-16 Phosphodiesterase 8a

Publications (1)

Publication Number Publication Date
BR9806318A true BR9806318A (pt) 2000-03-14

Family

ID=25491965

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9806318-9A BR9806318A (pt) 1997-10-16 1998-10-16 Polipeptìdeo pde8, polinucleotìdeo codificando o mesmo, dna, polinucleotìdeo anti-sentido, construção de expressão, célula hospedeira, processo para produzir um polipeptìdeo pde8, anticorpo, hibridoma, anticorpo anti-idiotipo, processo para identificar um composto parceiro de ligação espefcìfico de um polipeptìdeo pde8a, e de polinucleotìdeo pde8a, composto, e, composição.

Country Status (14)

Country Link
US (4) US5932465A (ja)
EP (2) EP1571216A3 (ja)
JP (1) JP2001512327A (ja)
CN (2) CN1229499C (ja)
AT (1) ATE295423T1 (ja)
AU (1) AU1097499A (ja)
BR (1) BR9806318A (ja)
CA (1) CA2275135A1 (ja)
DE (1) DE69830143T2 (ja)
ES (1) ES2245485T3 (ja)
IL (3) IL130287A0 (ja)
NO (1) NO992916L (ja)
RU (2) RU2272841C2 (ja)
WO (1) WO1999019495A1 (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2238283C (en) 1997-05-30 2002-08-20 Cell Pathways, Inc. Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
EP0967284A1 (en) * 1998-05-28 1999-12-29 Pfizer Limited Phosphodiesterases
US6130053A (en) * 1999-08-03 2000-10-10 Cell Pathways, Inc. Method for selecting compounds for inhibition of neoplastic lesions
GB9922125D0 (en) 1999-09-17 1999-11-17 Pfizer Ltd Phosphodiesterase enzymes
US6673564B2 (en) * 1999-10-18 2004-01-06 Millennium Pharmaceuticals, Inc. Methods for using 22045, a human cyclic nucleotide phosphodiesterase
CN1297049A (zh) * 1999-11-23 2001-05-30 上海博容基因开发有限公司 一种新的多肽——人环磷酸鸟嘌呤抑制的磷酸二酯酶17和编码这种多肽的多核苷酸
US6555547B1 (en) 2000-02-28 2003-04-29 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative
US6569638B1 (en) 2000-03-03 2003-05-27 Cell Pathways, Inc Method for screening compounds for the treatment of neoplasia
CN1312381A (zh) * 2000-03-07 2001-09-12 上海博德基因开发有限公司 一种新的多肽——人环腺苷酸磷酸二脂酶13和编码这种多肽的多核苷酸
AU2001289034A1 (en) * 2000-09-12 2002-03-26 Joseph A. Beavo Novel pdes and uses thereof
JP4999255B2 (ja) * 2001-07-10 2012-08-15 レイクウッド−アメディックス，インコーポレーテッド オリゴヌクレオチド含有薬理学的組成物およびその使用
EP1604035A2 (en) * 2002-11-08 2005-12-14 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a)
EP1786833A4 (en) * 2004-03-19 2009-02-25 Univ Yale DETECTION, INSULATION AND USE OF RENALASE (MONOAMINOXIDASE C)
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
TW200738255A (en) 2005-11-21 2007-10-16 Univ Yale Methods of regulating renalase (Monoamine Oxidase C)
BRPI0809244A2 (pt) * 2007-03-27 2014-09-23 Omeros Corp Métodos de tratamento de uma anormalidade de movimento, e para identificação de um agente que inibe a atividade pde7.
EP2430191B1 (en) * 2009-05-12 2018-09-19 Koninklijke Philips N.V. Phosphodiesterase 4d7 as prostate cancer marker
WO2012125182A1 (en) * 2011-03-11 2012-09-20 Synageva Biopharma Corp Npp1 fusion proteins
RU2760943C2 (ru) * 2011-09-15 2021-12-01 Алексион Фармасьютикалз, Инк. Гибридные белки NPP1
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69031172T2 (de) * 1989-12-22 1998-03-12 Applied Research Systems Modifikation der endogenen genexpression mit hilfe eines regulatorischen elements mittels homologe rekombination
AU664847B2 (en) * 1991-05-15 1995-12-07 Cell Genesys, Inc. Genomic modifications with homologous DNA targeting
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US5798246A (en) * 1996-03-25 1998-08-25 Incyte Pharmaceuticals, Inc. Cyclic nucleotide phosphodiesterase

Also Published As

Publication number Publication date
AU1097499A (en) 1999-05-03
NO992916L (no) 1999-08-06
IL130287A (en) 2006-08-20
ATE295423T1 (de) 2005-05-15
US6566087B1 (en) 2003-05-20
US20030215919A1 (en) 2003-11-20
NO992916D0 (no) 1999-06-15
IL130287A0 (en) 2000-06-01
IL175698A0 (en) 2008-02-09
US5932465A (en) 1999-08-03
DE69830143T2 (de) 2006-03-02
CN1800399A (zh) 2006-07-12
ES2245485T3 (es) 2006-01-01
US6133007A (en) 2000-10-17
RU2005136013A (ru) 2007-05-27
RU2272841C2 (ru) 2006-03-27
EP0944725A1 (en) 1999-09-29
CN1248291A (zh) 2000-03-22
EP0944725B1 (en) 2005-05-11
WO1999019495A1 (en) 1999-04-22
DE69830143D1 (en) 2005-06-16
CN1229499C (zh) 2005-11-30
JP2001512327A (ja) 2001-08-21
CA2275135A1 (en) 1999-04-22
EP1571216A2 (en) 2005-09-07
EP1571216A3 (en) 2006-04-26

Similar Documents

Publication Publication Date Title
BR9806318A (pt) Polipeptìdeo pde8, polinucleotìdeo codificando o mesmo, dna, polinucleotìdeo anti-sentido, construção de expressão, célula hospedeira, processo para produzir um polipeptìdeo pde8, anticorpo, hibridoma, anticorpo anti-idiotipo, processo para identificar um composto parceiro de ligação espefcìfico de um polipeptìdeo pde8a, e de polinucleotìdeo pde8a, composto, e, composição.
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
IL193886A0 (en) Antibodies that bind to ldcam sequences
BR9809778A (pt) Polinucleotìdeo isolado, vetor de expressão, peptìdeo ou polipetìdeo isolado, anticorpo, processo para produzir o mesmo, fragmentos de anticorpos, anticorpos de cadeia única ou anticorpos humanizados, e, anticorpo anti-idiotìpico.
NO20074516L (no) Pattedyrcytokinlignende polypeptid-1
BR9813608B1 (pt) célula hospedeira de bacillus transgênica, e, processo para produzir um polipeptìdeo tendo atividade aminopeptidase.
BR9810654B1 (pt) mÉtodo de preparaÇço de um polipeptÍdeo, molÉculas de anticorpo e composiÇço.
WO2003004622A3 (en) Human secreted proteins
ATE393222T1 (de) Dcr3 polypeptid, ein tnfr homolog
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
WO1997008314A3 (en) Telomere repeat binding factor and diagnostic and therapeutic use thereof
EP0739350A4 (en) LIGAND FIXING FAS ANTIGEN
KR930700661A (ko) 다양한 cd44 표면단백질, 이단백질을 코딩하는 dna 서열, 이단백질에 대한 항체와 진단과 치료의 용도
WO1999042596A3 (en) Phosphodiesterase 10
DK1032672T3 (da) DNA19355-polypeptid, en tumornekrosefaktor-homolog
WO1998031795A3 (en) Novel human metallothionein
WO1999010504A3 (en) Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use
WO1998018822A3 (en) Novel human lim proteins
DE69433902D1 (de) Neuartige tyrosinkinase
BR9910568A (pt) Anticorpos agonistas de receptor de g-csf e processo de seleção para os mesmos
WO1999061468A3 (en) The induction of antibiotic peptides by lait (scd14) protein
WO1998031805A3 (en) Human zinc binding proteins
KR940008700A (ko) 사람형 모노클로날 항펩티드 항체 및 이것을 코드하는 dna
EP1331265A3 (en) density enhanced protein tyrosine phosphatases
WO2002044375A3 (en) Compositions and methods for diagnosing or treating psoriasis

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR.